• Why the Costa share price is sinking lower today

    man looking down falling line chart, falling share price

    The Costa Group Holdings Ltd (ASX: CGC) share price is on course to end the week in the red.

    The horticulture company’s shares are down over 3.5% to $3.18 in early trade.

    Why is the Costa share price dropping lower?

    Investors have been selling Costa’s shares following the release of its annual general meeting presentation this morning.

    After losing its chief financial officer earlier this month, today’s update reveals that another senior executive is on the way out. This time around it is Chief Executive Officer Harry Debney that is leaving.  

    According to the update, after over 10 years leading the company, Mr Debney plans to retire from the role within the next nine months. As such, the company and chief executive are currently in discussions regarding an orderly retirement transition plan. This includes looking internally an externally for a successor.

    What else did the company announce?

    After acknowledging that 2019 was a difficult year, management appears pleased with its performance year to date. Especially given the headwinds it faced early in the year.

    The company notes that the majority of its core produce categories are now experiencing positive demand and pricing from the retail sector. Furthermore, its farming operations are meeting yield and quality expectations.

    However, while there are no adverse effects from COVID-19 on its production, it notes that mitigation costs are considerable.

    These costs relate to an action plan the covers daily temperature testing, heightened hygiene protocols, and social distancing procedures. It has also had to deal with a fractured supply chain, from logistics through to ensuring it had an adequate labour force to meet its harvest needs.

    As a result, the company has no plans to reinstate any form of guidance for FY 2020 at this time. Which means investors may have to wait patiently until its results in August to see how the company is truly performing.

    Not sure about Costa right now? Then the five dirt cheap shares recommended below might be the ones to buy…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the Costa share price is sinking lower today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2TJhUKb

  • 3 dirt cheap ASX shares to buy before it is too late

    Man in white business shirt touches screen with happy smile symbol

    Although a number of shares have been hitting 52-week or record highs this week like Afterpay Ltd (ASX: APT), not all shares are trading close to these levels.

    A few top ASX shares are still trading at levels which I think make them cheap. Here’s why I would buy them:

    Aristocrat Leisure Limited (ASX: ALL)

    The Aristocrat Leisure share price is down 30% from its 52-week high. The catalyst for this decline has been the closure of casinos during the pandemic. As well as losing out on potential sales, the company was missing out on daily fees for its poker machines. The good news is that casinos are reopening and demand should soon pick up for its industry-leading machines. Another positive is that during the pandemic the company’s digital business has been booming. It now has 7.3 million daily active users playing its games which are generating significant recurring revenues.

    Sydney Airport Holdings Pty Ltd (ASX: SYD)

    The Sydney Airport share price has fallen 35% from its 52-week high. This has of course been driven by the collapse in tourism because of the pandemic. However, I feel this decline has been excessive and created a buying opportunity for patient investors. Especially with tourism markets likely to start recovering in the coming months. I expect domestic tourism to begin its recovery in the near future, with international tourism to follow in 2021. Based on this, I believe the company’s dividend could return to previous levels in 2022.

    Telstra Corporation Ltd (ASX: TLS)

    The Telstra share price is down 20% from its 52-week high, which I think is a buying opportunity for investors. This is because after years of struggles, the telco giant appears to be close to returning to growth. Especially given the early success of its T22 strategy, which is creating a much leaner operation. Combined with easing NBN headwinds and the arrival of 5G internet, I think Telstra could prove to be a great long term investment.

    And here are five dirt cheap ASX shares which analysts expect to rebound very strongly when the crisis passes…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 dirt cheap ASX shares to buy before it is too late appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2M8Pt46

  • 2 ASX 200 tech shares I’d like to buy today

    Circuit board, Altium shares

    S&P/ASX 200 Index (ASX: XJO) tech stocks have been volatile in 2020, but it has been a mixed bag of performances. Not every ASX 200 tech share has performed as well as Afterpay Ltd (ASX: APT) this year, which means there are many still in the buy zone.

    Here are a couple of my top picks that are trading at a good price today.

    2 ASX 200 tech shares I’d like to buy today

    I think Xero Limited (ASX: XRO) shares are worth a look right now. The Xero share price has rocketed 343.86% higher in the last 5 years but has edged just 6.25% higher in 2020.

    Xero provides accounting software platform to small and medium-sized businesses and could see steady earnings despite the coronavirus pandemic.

    While some customers may not renew their subscriptions, I think the complexity arising from the JobKeeper stimulus package could be where Xero comes into its own. That’s good for earnings and the Xero share price.

    I also like the look of Altium Limited (ASX: ALU) shares right now.

    Altium provides electronics design software for engineers who design printed circuit boards. As the global economy emerges from hibernation, I think business could pick up again for this Aussie tech group.

    Altium shares are up 19.77% this year, which means its already a strong performer. However, it is currently trading at $37.02 per share (at the time of writing), compared to an all-time high of $42.76.

    I think Altium could be an ASX top 50 or even top 20 share within the next decade. With a $4.85 billion market capitalisation right now, Altium is well-placed to capitalise on the changing tech scene here in Australia.

    Foolish takeaway

    Both Altium and Xero are successful ASX 200 tech shares that have rocketed higher in recent years.

    However, I think a recovering economy and strong client base could be the key to boost both share prices even higher in 2020.

    For more companies to add to your watchlist, check out these 5 cheap ASX shares today!

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of Altium. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 ASX 200 tech shares I’d like to buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2AgrLQH

  • Novavax (NVAX) Stock Is a Winner, but How Much Higher Can It Go?

    Novavax (NVAX) Stock Is a Winner, but How Much Higher Can It Go?Volatility is nothing new in the healthcare sector. Nonetheless, vaccine player Novavax’s (NVAX) recent spectacular moon bound rally is on another level.The stock surged by another 147% this month, cumulatively accruing 1025% of gains in 2020. Which begs the far-fetched question: Has Novavax provided the coveted vaccine? Not yet, but it is taking some big strides towards addressing the issue.The latest share appreciation came following news that the coalition for Epidemic Preparedness Innovations (CEPI) will commit up to $388 million to further the development of Novavax’ vaccine candidate against COVID-19 (SARS-CoV-2), NVX-CoV2373. The investment is CEPI’s biggest to date and follows on from what now feels like a miniscule initial $4 million grant to Novavax.In tandem with setting the process of clinical trials in motion (with Phase 1/2 trial data expected by July), part of the funding will go towards ramping up production at various locations around the globe, with a target of matching the largest pharma vaccine developers’ production capacity.Based on Novavax’ vaccine track record, Ladenburg Thalmann analyst Michael Higgins is confident in the outcome, and predicts the Phase 1/2 results “will prove to be safe.” The results are key to his thesis of Novavax’ rNPV (risk-adjusted net present value) as the data will have an impact on the “scale up activities.”Higgins expounded, “While CEPI and Novavax are working collectively to generate the manufacturing capabilities to reach one billion doses in 2021, we are modeling the 100M doses are sold in 2021 at $10/dose, with 50% net margins. Mgt has not provided guidance on our assumptions; but given the low net manufacturing costs (especially on a large scale) we believe our assumptions are within reasonable expectations. We believe the low manufacturing margins contributed to CEPI’s decision, as it seeks to partner with innovators to treat as many global citizens as possible.”Overall, Novavax gets 100% support from the Street, as all 5 analysts tracked over the last 3 months rate the vaccine player a Buy. With an average price target of $49.20, the analyst fraternity projects upside of nearly 10%. (See Novavax stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

    from Yahoo Finance https://ift.tt/36DWtPS

  • Why I think the CSL share price is a strong buy today

    Healthcare shares

    The CSL Limited (ASX: CSL) share price edged 0.17% lower yesterday to close at $287.51 per share. The Aussie biotech’s shares have climbed as high as $342.75 in 2020 before slumping in late May.

    Here are a few reasons why I think CSL could be a strong buy at its current price.

    Why the CSL share price could be a strong buy

    CSL is amongst the largest ASX 200 shares on the market with a $130.54 billion market cap. I think the CSL share price could be a buy, given large caps have tended to outperform small caps in past market downturns.

    The company is a leading healthcare player, which should help support CSL’s valuation in 2020. The Aussie company has a strong presence in both rare and serious diseases and influenza vaccines and antivenoms.

    Given its areas of specialisation, you may have expected the CSL share price to soar amid the coronavirus pandemic. However, CSL isn’t heavily involved in the race for a COVID-19 vaccination.

    That being said, the biotech giant has partnered with the University of Queensland in a COVID-19 vaccine development program. CSL is also investigating the role that immunoglobulin could play in terms of COVID-19 treatment here in Australia.

    I think much of CSL’s earnings will continue to hold up despite the pandemic. The Aussie healthcare group already reaffirmed its earnings guidance in April 2020.

    That alone doesn’t mean the CSL share price is in the buy zone. I think the key is to not overpay, even for high-quality ASX shares.

    At $287.51 per share, I think CSL is trading cheaply right now. Even in the midst of the recent bear market, CSL shares fell to just $270.88 on 20 March.

    The current price-to-earnings ratio of 42.55 times does look a touch high. However, I think the support around the current CSL share price level combined with a strong earnings profile is worth paying for in the current market. 

    If CSL isn’t in your buy basket right now, check out these 5 cheap ASX shares instead!

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why I think the CSL share price is a strong buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XEVKd9

  • President Trump signs social media executive order

    President Trump signs social media executive orderPresident Donald Trump signed an executive order targeting social media companies. Yahoo Finance’s Alexis Keenan breaks down the details of the executive order on The Final Round.

    from Yahoo Finance https://ift.tt/3grPbmV

  • 10 quality ASX shares to buy in June

    Buy Shares

    A new month is on the horizon, so what better time to see if your portfolio could do with some new additions.

    Below I have picked out 10 quality ASX shares which I think have the potential to be market beaters in the coming years. Here’s why I would buy them in June:

    a2 Milk Company Ltd (ASX: A2M)

    I continue to believe that a2 Milk Company would be a great ASX share to own. This is largely down to the increasing demand for its infant formula in China and its relatively modest market share in the lucrative market.

    Altium Limited (ASX: ALU)

    Altium is an award-winning printed circuit board (PCB) design software provider. Over the last few years it has carved out a leading position in this growing market. Which is a big positive given the proliferation of electronic devices. This is likely to lead to increasing demand for its software over the next decade.

    Appen Ltd (ASX: APX)

    Another ASX share to consider is Appen. It is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). Appen prepares or creates the data for the machine learning models of some of the largest tech companies such as Facebook and Microsoft. It also assisted in the creation of Apple’s Siri.

    Aristocrat Leisure Limited (ASX: ALL)

    This gaming technology company’s shares have fallen heavily this year due to the pandemic. The good news is that casinos are now starting to reopen, which should lead to a rebound in demand for its poker machines. In addition to this, its Digital business has been booming during lockdowns and is generating material recurring revenues.

    CSL Limited (ASX: CSL)

    I think this biotherapeutics giant could be a great long term option. I continue to believe CSL will be a market beater over the next decade. This is thanks to the increasing demand for immunoglobulins, its growing plasma collection network, and its pipeline of potentially lucrative products.

    Kogan.com Ltd (ASX: KGN)

    This ecommerce company’s shares have been on fire over the last couple of months thanks to a spike in sales and customer growth during the pandemic. Despite this, I would still be a buyer of its shares with a long term view. Especially given how the crisis appears to have accelerated the structural shift to online shopping.

    Megaport Ltd (ASX: MP1)

    Megaport is an elasticity connectivity and network services company. Its increasingly popular service allows users to increase and decrease their available bandwidth in response to their own demand requirements. This is instead of a user being tied to a fixed service level on long-term and expensive contracts. Demand for its service has been growing very strongly, leading to stellar recurring revenue growth.

    Nanosonics Ltd (ASX: NAN)

    Another ASX share to consider is Nanosonics. It is an infection control specialist which I believe has exceptionally strong growth potential. This is due to the sizeable market opportunity of its industry-leading trophon EPR disinfection system for ultrasound probes and the impending release of new products. These products are targeting other unmet needs in a market which infection control is becoming increasingly important.

    Pushpay Holdings Group Ltd (ASX: PPH)

    Pushpay is a fast-growing donor management platform provider for the faith and not-for-profit sectors. It has been growing its earnings at a rapid rate over the last couple of years and recently provided guidance for more strong growth in FY 2021. Looking further ahead, it is targeting a 50% share of the medium to large church market. This is a US$1 billion opportunity and many multiples of its current revenue.

    ResMed Inc. (ASX: RMD)

    A final ASX share to buy is ResMed. It is a medical device company with a focus on the sleep treatment market. I believe it is in a strong position for growth due to its industry-leading products and massive market opportunity. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide. However, only ~20% of these sufferers have been diagnosed.

    And if you still have space for more shares, these five recommendations below look like potential market beaters…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd., MEGAPORT FPO, and Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of A2 Milk, Altium, and Appen Ltd. The Motley Fool Australia has recommended MEGAPORT FPO, Nanosonics Limited, and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 10 quality ASX shares to buy in June appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2BcQpSR

  • Is the Telstra share price a buy?

    Telecommunications, phone

    Is the Telstra Corporation Ltd (ASX: TLS) share price a buy? The telco could be one of the most defensive shares within the ASX 20.

    We’ve already seen during this period how uncertain shares like Commonwealth Bank of Australia (ASX: CBA), Westpac Banking Corp (ASX: WBC), National Australia Bank Ltd (ASX: NAB) and Australia and New Zealand Banking Group (ASX: ANZ) can be at a time like the coronavirus.

    I don’t know about you, but the internet has been one of the main things that has helped during this coronavirus period. Whether that’s communication, entertainment, work – Telstra (and other telcos) help deliver that imperative service.

    The Telstra share price has been rightly falling over the past five years. The NBN has cut into profit margins and there has been strong price competition on 4G mobile.

    5G could change everything for the Telstra share price

    A new technology has the potential to change everything. New technology offers growth potential we don’t even know of yet. We couldn’t have imagined how many new services would have become mainstream in the world thanks to 4G. Various Alphabet (Google) offerings, Facebook, ridesharing, food delivery and so on. Telstra’s share price and earnings hasn’t captured much of this value.

    What’s going to happen with 5G? Well technology like automated cars and virtual reality or augmented reality are already planned services. That alone will be a huge change for life.

    But we don’t yet know what the economics of what 5G will be. How much will customers have to pay each month? Will we have to pay monthly for things like our car?

    How the pricing is structured is important. What’s to stop 5G just turning into a price competition like 4G has? That would be bad for the Telstra share price.

    At the moment Telstra is in a good position. It’s probably going to be (one of) the first to bring 5G to the national Australian market. The delayed merger between TPG Telecom Ltd (ASX: TPM) and Vodafone Australia may help Telstra. First, there may be less price competition (and higher margins). Second the initial block by the ACCC has meant that TPG and Vodafone are behind Telstra in the 5G construction timetable.

    Foolish takeaway

    Is the Telstra share price a buy? Well the telco is investing heavily for 5G which is good. But FY20 may not show any profit growth despite all of the useful cost savings it has been implementing. It’s trading at 18x FY21’s estimated earnings. I want to wait until seeing how 5G will help Telstra before buying. I think I’d rather buy TPG today. There are plenty of other shares I’d rather buy in the ASX 200 too.

    I think these shares are much better value with more likely, and more exciting, growth in store:

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the Telstra share price a buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3gqVirs

  • Buy this ASX 200 dividend share now for an 18% return in a month

    Cloud against blue sky with cash falling from it

    ASX 200 dividend share Orora Ltd (ASX: ORA) is paying a 50% franked dividend of $0.373 per share. At Thursday’s closing price, this equates to a dividend yield of 14.3%. The company goes ex-dividend on 19 June. This means that as long as you buy before that date, you get the dividend.

    Moreover, the company has announced an additional return of capital from a recent asset sale. This raises the overall payment to 18.8% at time of writing for this dividend share. 

    Orora’s share price has a history of rising prior to the ex-dividend date. The higher the share price you buy in at, the lower the dividend yield, so it would be wise to act very quickly to secure a high yield.

    Dividend history

    Over a 6-year period, Orora has grown its dividend payment by an average of 13.8% every year. The company also shows all the signs of being well managed. It grows its earnings per share every year, and its share price has also grown by an average of 14% per year over a 6-year period.

    Company overview

    Orora operates a beverage and packaging business in Australia and the United States. It produces bottles, boxes, cartons and aluminium cans, and general packing products. In October 2019 it sold its Australasian fibre business to Japan’s Nippon for $1.7 billion. This provided the company with a $1.2 billion windfall, half of which it will be returning to shareholders alongside the dividend payment. 

    At the time of writing, Orora is selling at a price-to-earnings ratio (P/E) of 22.22. This is below the company’s 10-year average. So while it is high, the market has factored in growth given the company’s management history. The Orora share price is still down by 16%, year to date.

    Foolish takeaway

    I believe this dividend share is a rare income and value investing opportunity. Orora is a good company at a good price with an 18% definite payment within less than a month. The scope for future share price growth is very high over the medium term, and the company will likely continue to pay reasonable dividends based on its history. However, for taxation purposes only 50% of the initial dividend payment is franked.

    Be sure to download our free report on another great income producing share.

    NEW: Expert names top dividend stock for 2020 (free report)

    When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*

    Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.

    This fully franked “under the radar” company is currently trading more than 24% below its all-time high and paying a 6.7% grossed-up dividend.

    The name of this dividend dynamo and the full investment case is revealed in this brand new free report.

    But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.

    See the top dividend stock for 2020

    More reading

    Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Buy this ASX 200 dividend share now for an 18% return in a month appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3cbjRFD

  • New United Airlines CEO Says No To Bankruptcy and Mandating Blocked Middle Seats

    New United Airlines CEO Says No To Bankruptcy and Mandating Blocked Middle SeatsAt two previous companies, new United Airlines CEO Scott Kirby developed a reputation for bluntness, often favoring honest answers over diplomatic ones. On Thursday, speaking at his first public forum since taking over last week from Oscar Munoz, Kirby showed he wouldn't drop the act just because he now leads a Fortune 100 company. In […]

    from Yahoo Finance https://ift.tt/3cgmndv